Literature DB >> 9681640

Apo E and Apo CI loci are associated with dementia in younger but not older late-onset cases.

C Tysoe1, D Galinsky, D Robinson, C Brayne, F A Huppert, T Dening, E S Paykel, D F Easton, D C Rubinsztein.   

Abstract

Numerous groups have confirmed that apolipoprotein E allelic variation accounts for a proportion of the genetic risk for late-onset Alzheimer's disease (AD). However, there is a paucity of data on the impact of this locus on the overall risk of dementia (as opposed to AD) in the elderly. Most studies have ascertained specifically AD cases from hospital clinics or brain banks and many demented cases have vascular dementia or mixed AD and vascular pathology. We have examined the closely linked apo E and apo CI loci in demented cases and non-demented controls from two community-based aged Cambridgeshire populations: the rural Ely population (cohort 1) comprised 60 pairs of demented and non-demented elderly individuals, with a mean age of 84.2 years (SD = 6.11); the Cambridge city population (cohort 2) comprised 81 pairs all aged over 84 with a mean age of 87.7 years (SD = 2.9). The younger Ely cohort showed significant allelic associations with dementia at the apo E and apo CI loci, which were not replicated in the older Cambridge cohort. These data suggest the possibility of age-dependent penetrance for different candidate genes in late-onset dementia. We propose a number of explanations to account for the stronger associations we observed between dementia and apo CI, compared to the neighbouring apo E locus. Our data are compatible with the possibility that specific alleles or genotypes may confer different risks for overall dementia, compared to AD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681640     DOI: 10.1159/000017046

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  4 in total

1.  Effects of HLA-DRB1/DQB1 Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and Alzheimer's Disease Cohorts.

Authors:  Zi-Xuan Wang; Hui-Fu Wang; Lin Tan; Jinyuan Liu; Yu Wan; Fu-Rong Sun; Meng-Shan Tan; Chen-Chen Tan; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-04-07       Impact factor: 5.590

2.  Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

Authors:  David A Elliott; Cyndi Shannon Weickert; Brett Garner
Journal:  Clin Lipidol       Date:  2010-08-01

3.  Apolipoproteins E and C1 and brain morphology in memory impaired elders.

Authors:  J M Serra-Grabulosa; P Salgado-Pineda; C Junqué; C Solé-Padullés; P Moral; A López-Alomar; T López; A López-Guillén; N Bargalló; J M Mercader; I C Clemente; D Bartrés-Faz
Journal:  Neurogenetics       Date:  2002-12-21       Impact factor: 2.660

4.  Genetic studies in Alzheimer's disease.

Authors:  Ya-Ping Tang; Elliot S Gershon
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.